A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

NCT05889988 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Mayo Clinic